Self-Administered, Painless Flu Vaccine Patch - Success in First Human Clinical Trial
Added Jul 13, 2017 | Rate View top rated
Despite the recommendation of universal flu vaccination, influenza continues to be a major cause of illness leading to mortality. Georgia Tech researchers believe a new self-administered, painless vaccine skin patch containing microscopic needles could significantly increase the number of people who get vaccinated for the flu. A phase I clinical trial conducted by Emory University in collaboration with the Georgia Tech researchers has found that influenza vaccination using Band-Aid-like patches with dissolvable microneedles was safe and well-tolerated by study participants, was just as effective in generating immunity against influenza, and was strongly preferred by study participants over vaccination with a hypodermic needle and syringe. The microneedle patch vaccine could also save money because it is easily self-administered, could be transported and stored without refrigeration, and is easily disposed of after use without sharps waste.

Be the first to comment. Please sign in to add your thoughts below.
Watch more